title: Stage-related changes in functional capacity in Hodgkin's disease: assessment by cardiopulmonary exercise testing before initiation of treatment.
abstract: Our aim was to examine indices of cardiorespiratory capacity at rest and during exercise before initiation of therapy for Hodgkin's disease. We prospectively studied 24 patients divided into two groups according to the disease stage. Group 1 included eight patients in stage IA and four in stage IIA; group 2 included four patients in stage IIB, six in stage III, and two in stage IV. All patients underwent detailed cardiopulmonary evaluations at rest using electrocardiogram, echocardiogram, spirometry, and measurement of pulmonary diffusing capacity (DLCO), and during exercise using a cardiopulmonary exercise test. Groups 1 and 2 were similar with respect to sex distribution (eight women and four men in each), mean age (35+/-36 vs37+/-4.6 years), body mass index, and hemoglobin concentration (12.7+/-0.2 vs 12.1+/-0.3 g l-1). All patients had a normal cardiovascular status. All patients in group 1 had normal cardiorespiratory measurements at rest and during exercise. Forced vital capacity was significantly lower in group 2 (84.8+/-2.7% predicted) than in group 1 (105+/-3%, P<0.0001), without abnormalities in DLCO or in resting and exercise oxygen diffusion. Likewise, percentage predicted VO2max (65+/-4 vs 97+/-6, P<0.0002), oxygen pulse at peak exercise (0.12+/-0.01 vs 0.17+/-0.01, P<0.001), and DeltaVO2/DeltaW slope (8.4+/-0.3 vs 10.2+/-0.4, P<0.003) were significantly lower in group 2 than in group 1. Functional capacity during exercise was markedly reduced in patients suffering from Hodgkin's disease in advanced stages. This loss of exercise capacity appeared mainly related to a peripheral disorder.
authors.affiliation: UCP.X, Laboratoire de Physiopathologie de l'Exercice, Grenoble, France. ericpagecardio@wanadoo.fr
authors.forename: Eric
authors.initials: E
authors.lastname: Page
authors.forename: David
authors.initials: D
authors.lastname: Assouline
authors.forename: Catherine
authors.initials: C
authors.lastname: Durand
authors.forename: Odile
authors.initials: O
authors.lastname: Brun
authors.forename: David
authors.initials: D
authors.lastname: Coeffic
authors.forename: Danièle
authors.initials: D
authors.lastname: Fric
authors.forename: Claire
authors.initials: C
authors.lastname: Garnier
authors.forename: Cécile
authors.initials: C
authors.lastname: Leyronnas
authors.forename: Véronique
authors.initials: V
authors.lastname: Alcalay
authors.forename: Bernard
authors.initials: B
authors.lastname: Aguilaniu
mesh_terms: D000328:Adult; D002320:Cardiovascular Physiological Phenomena; D004452:Echocardiography; D004562:Electrocardiography; D005080:Exercise Test; D017079:Exercise Tolerance / Q000502:physiology*; D005260:Female; D006689:Hodgkin Disease / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008168:Lung / Q000503:physiopathology*; D008297:Male; D009367:Neoplasm Staging; D011653:Pulmonary Diffusing Capacity; D014797:Vital Capacity